# TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan Criterial

> **NCT03636620** · PHASE3 · COMPLETED · sponsor: **Fudan University** · enrollment: 110 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DEVICE:** Transcatheter arterial chemoembolization
- **DEVICE:** radiofrequency ablation/microwave ablation

## Key facts

- **NCT ID:** NCT03636620
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2018-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03636620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03636620, "TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan Criterial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03636620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*